Análisis de Dispositivos Ortopédicos Aprobados por la FDA y Sus Retiros
PMID: 26984921 ·
C, h, a, r, l, e, s, , S, , D, a, y, ;, , D, a, v, i, d, , J, , P, a, r, k, ;, , F, r, e, d, e, r, i, c, k, , S, , R, o, z, e, n, s, h, t, e, y, n, ;, , N, a, n, a, , O, w, u, s, u, -, S, a, r, p, o, n, g, ;, , A, l, d, e, b, a, r, a, n, i, , G, o, n, z, a, l, e, z
Publicidad
Resumen
The U.S. Food and Drug Administration (FDA) evaluates medical devices by two main pathways. The more stringent Premarket Approval (PMA) review requires clinical trials, and the Premarket Notification 510(k) process generally exempts devices from clinical trials if they prove to be substantially equivalent to existing devices. We hypothesized that orthopaedic devices are more likely to be cleared through the 510(k) process and thus are more susceptible to being recalled. Using the FDA's public da
Publicidad
Fuente oficial
Ver en PubMed →Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.